Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wermuth, L.
Right arrow Articles by Jeune, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wermuth, L.
Right arrow Articles by Jeune, B.
NEUROLOGY 1997;49:426-432
© 1997 American Academy of Neurology

High prevalence of Parkinson's disease in the Faroe Islands

Lene Wermuth, MD, Poul Joensen, MD, Nick Bünger, MD and Bernard Jeune, MD

From the Department of Neurology (Dr. Wermuth), Odense University Hospital, Denmark; the National Hospital in Thorshavn (Dr. Joensen), the Faroe Islands; the Department of Psychiatry (Dr. Bünger), Svendborg Hospital, and the Department of Epidemiology (Dr. Jeune), Odense University Medical School, Denmark.

Address correspondence and reprint requests to Dr. Lene Wermuth, Department of Neurology, Odense University Hospital, DK-5000 Odense C, Denmark.

We used several case-findings methods and strict criteria for case ascertainment to diagnose parkinsonism and idiopathic Parkinson's disease(PD) in the Faroe Islands. In the last few years before the prevalence date of July 1, 1995, we searched various registries from pharmacies, hospitals, and general practices, and found 195 patients with suspected parkinsonism out of 43,709 inhabitants. After excluding those who died before the prevalence date or were treated with levodopa (LD) for other diseases, a total of 124 patients remained for study, of whom 122 participated. We found 102 patients with parkinsonism and 82 with PD versus the expected 53 (p < 0.001, age-specific prevalences in the county of Rogaland, Norway). The overall prevalence of PD was estimated to be 187.6 and the age-adjusted prevalence to be 183.3 versus 110.9 per 100,000 inhabitants in the county of Rogaland. Compared to the study from Rogaland, the mean age at onset of PD symptoms, the mean age at the prevalence date, and the duration of PD indicated that the higher prevalence was not due to either an early onset nor to a longer duration of PD. A lower proportion of definite PD, a lower mean score on the Hoehn-Yahr scale, and a lower average dose of LD suggest that the high prevalence may be due to early diagnosis and a higher ascertainment of cases with mild disease. However, a high incidence cannot be excluded.


Supported by the Danish and the Faroe Islands Parkinson Foundation.

Received November 23, 1996. Accepted in final form March 5, 1997.




This article has been cited by other articles:


Home page
Arch NeurolHome page
J. R. Richardson, S. L. Shalat, B. Buckley, B. Winnik, P. O'Suilleabhain, R. Diaz-Arrastia, J. Reisch, and D. C. German
Elevated Serum Pesticide Levels and Risk of Parkinson Disease
Arch Neurol, July 1, 2009; 66(7): 870 - 875.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky
How common are the "common" neurologic disorders?
Neurology, January 30, 2007; 68(5): 326 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Ngai, Y.M. Tang, L. Du, and S. Stuckey
Hyperintensity of the Middle Cerebellar Peduncles on Fluid-Attenuated Inversion Recovery Imaging: Variation with Age and Implications for the Diagnosis of Multiple System Atrophy
AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2146 - 2148.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
C. Zampieri and R. P Di Fabio
Progressive Supranuclear Palsy: Disease Profile and Rehabilitation Strategies
Physical Therapy, June 1, 2006; 86(6): 870 - 880.
[Full Text] [PDF]


Home page
NeurologyHome page
B. Kis, A. Schrag, Y. Ben-Shlomo, C. Klein, A. Gasperi, F. Spoegler, R. Schoenhuber, and P. P. Pramstaller
Novel three-stage ascertainment method: Prevalence of PD and parkinsonism in South Tyrol, Italy
Neurology, June 25, 2002; 58(12): 1820 - 1825.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Wermuth, H. Pakkenberg, and B. Jeune
High age-adjusted prevalence of Parkinson's disease among Inuits in Greenland
Neurology, May 14, 2002; 58(9): 1422 - 1425.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
U. Nath, Y. Ben-Shlomo, R. G. Thomson, H. R. Morris, N. W. Wood, A. J. Lees, and D. J. Burn
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK
Brain, July 1, 2001; 124(7): 1438 - 1449.
[Abstract] [Full Text] [PDF]